Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/56808
Title: Nasal spray ketamine/dexmedetomidine for pain relief
Monash Health Investigator(s): Shehabi Y. 
Monash Health Department(s): Peri-operative Services
Registration Date: 7-Feb-2020
Monash Health Site(s): Monash Medical Centre
Trial Phase: Not Applicable
Summary: Studies have consistently shown that ketamine and dexmedetomidine infusions on their own provide good and safe analgesia, decrease opioid requirements and can increase the pain-free period during the postoperative recovery. A combination of dexmedetomidine and ketamine may prevent adverse events associated with Ketamine use such as tachycardia, hypertension, salivation, as well as reduce anxiety from ketamine, whereas ketamine may prevent the bradycardia and hypotension, which has been reported with dexmedetomidine. What is more, IN is an attractive needle-free sedative option where IV access is unnecessary or may be deferred until sedation is achieved. Both ketamine and dexmedetomidine are efficacious and well tolerated when provided as an IN preparation. To our knowledge, however, very few studies have examined a combined formulation. This study will therefore seek evaluate the sedative, anxiolytic, and analgesic effects of combined dexmedetomidine and ketamine when administered via the nasal route in healthy adults.
Type: Clinical trial
Registry ID: ACTRN12620000117910
URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379062
Appears in Collections:Clinical Trials

Show full item record

Page view(s)

68
checked on May 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.